Daniel Lunz

Form D signer

Daniel Lunz

Chief Executive Officer at Capsulomics

Form D signer

Capital raised by Capsulomics

$2.4M+$2.4M latest round

1 Form D filing · first filed Dec 2019 · Halethorpe, MD

CURRENT ROLE: Chief Executive Officer
SECTOR: Healthcare
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: 1 ↗

Career

1 company on file

CapsulomicsHealthcare · Halethorpe, MDsince Dec 2019

Chief Executive Officer

Signatory on Capsulomics's Form D filings · $2.4M raised across 1

Company filings

via EDGAR · Form D for Capsulomics1

DateCompanyFormAmountRole on filing

Dec 17, 2019CapsulomicsForm D/A+$2.4MChief Executive Officer

Form D/ADec 17, 2019 · Capsulomics+$2.4Mas Chief Executive Officer

Overview

Last filing Dec 17, 2019

Daniel Lunz is on file as Chief Executive Officer at Capsulomics in Halethorpe, MD. Capsulomics has 1 Form D filing on record, $2.4M raised in total. Daniel Lunz appears as a signatory on the company's filings.

Teammates

Capsulomics · 1

William StevensExecutive Officer

Products

Capsulomics · 1

EsopredictMolecular Diagnostics

Esopredict is a cutting-edge molecular diagnostic test that assesses the risk of Barrett's esophagus patients progressing to high-grade dysplasia or esophageal adenocarcinoma. By analyzing DNA methylation biomarkers within esophageal tissue samples, it provides a personalized risk assessment for individuals already diagnosed with Barrett's esophagus.